Zentalis Pharmaceuticals, Inc. (ZNTL) Executive Compensation
Zentalis Pharmaceuticals, Inc. (ZNTL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ZNTL
CIK: 1725160
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerGraeme Reid
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0001628280-26-064317 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-19 | — | SCHEDULE 13G/A Filing | 0001213900-26-091824 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-14 | 4 Filing | 0001213900-26-091823 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001628280-26-057112 | View SEC Doc Filr Page |
| 424B5 | 2026-08-14 | — | 424B5 | 0001628280-26-057108 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000312069-26-000217 | View SEC Doc Filr Page |
| 424B5 | 2026-08-13 | — | 424B5 | 0001628280-26-056729 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001725160-26-000062 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001725160-26-000061 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003135 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001808098-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001838042-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001701440-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001843119-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | FORM 4 | 0001356256-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-16 | 8-K | 0001725160-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | FORM 4 | 0002018966-26-000005 | View SEC Doc Filr Page |
| 3 | 2026-05-27 | 2026-05-22 | FORM 3 | 0002018966-26-000004 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-27 | — | DEFA14A | 0001725160-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-22 | 8-K | 0001725160-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001725160-26-000045 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001725160-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001725160-26-000041 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | 8-K | 0001725160-26-000033 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001725160-26-000028 | View SEC Doc Filr Page |